Literature DB >> 1569426

Prospective study of serum cholesterol and site-specific cancers.

P H Chyou1, A M Nomura, G N Stemmermann, I Kato.   

Abstract

From 1965 to 1968, 7716 Japanese-American men were examined and tested for serum cholesterol. After 22 years, 1380 incident cancer cases were identified. Of the site-specific cancers, only colon cancer cases had a significantly lower mean serum cholesterol value than that of noncases (213.0 mg/dl vs 219.0 mg/dl). When the study subjects were separated into either a low, middle or high group, based on their serum cholesterol values, there was a significant inverse trend for cases of oral/pharyngeal/esophageal cancer combined. The association was present for cases diagnosed within 10 years of examination (p = 0.012), but not for cases diagnosed after 10 years. This suggests that the inverse association is due to the metabolic effects of undiagnosed oral/pharyngeal/esophageal cancer upon serum cholesterol levels. These results are discussed in relation to other studies on serum cholesterol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569426     DOI: 10.1016/0895-4356(92)90089-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

1.  Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.

Authors:  Mihael Sok; Janez Ravnik; Maja Ravnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Cholesterol as a potential target for castration-resistant prostate cancer.

Authors:  Alexis L Twiddy; Carlos G Leon; Kishor M Wasan
Journal:  Pharm Res       Date:  2010-08-04       Impact factor: 4.200

3.  Serum total and HDL cholesterol and risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-09-14       Impact factor: 2.506

4.  Total cholesterol and cancer risk in a large prospective study in Korea.

Authors:  Cari M Kitahara; Amy Berrington de González; Neal D Freedman; Rachel Huxley; Yejin Mok; Sun Ha Jee; Jonathan M Samet
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

5.  Alteration of Lipid Profile in Patients with Head and Neck Malignancy.

Authors:  Vijay Kumar Poorey; Pooja Thakur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-01-30

6.  Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.

Authors:  Alison M Mondul; Sandra L Clipp; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-10-06       Impact factor: 2.506

7.  Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study.

Authors:  T E Strandberg; V V Salomaa; H T Vanhanen; V A Naukkarinen; S J Sarna; T A Miettinen
Journal:  Br Heart J       Date:  1995-10

8.  Malignancy-associated dyslipidemia.

Authors:  Agata Bielecka-Dąbrowa; Simon Hannam; Jacek Rysz; Maciej Banach
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

9.  Lipid profile in oral submucous fibrosis.

Authors:  Ravi Mehrotra; Shruti Pandya; Ajay Kumar Chaudhary; Himanshu Pratap Singh; Ritesh Kumar Jaiswal; Mangal Singh; S C Gupta; Mamta Singh
Journal:  Lipids Health Dis       Date:  2009-07-24       Impact factor: 3.876

10.  Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study.

Authors:  Wahyu Wulaningsih; Hans Garmo; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.